-
Journal of Echocardiography Mar 2022
Topics: Carcinoma, Bronchogenic; Humans; Lung Neoplasms
PubMed: 33174124
DOI: 10.1007/s12574-020-00499-1 -
Seminars in Roentgenology Jul 1977
Review
Topics: Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Pulmonary Atelectasis; Radiography
PubMed: 329417
DOI: 10.1016/s0037-198x(77)80006-0 -
CA: a Cancer Journal For Clinicians 1979
Topics: Carcinoma, Bronchogenic; Humans; Lung Neoplasms; Neoplasm Staging; Radiography
PubMed: 110406
DOI: 10.3322/canjclin.29.4.233 -
World Journal of Surgery 1993Both computed tomography (CT) and magnetic resonance imaging (MRI) can provide important information not obtainable by chest radiography regarding staging of patients... (Review)
Review
Both computed tomography (CT) and magnetic resonance imaging (MRI) can provide important information not obtainable by chest radiography regarding staging of patients with bronchogenic carcinoma. However, while CT and MRI can both detect enlarged mediastinal nodes, this only approximately indicates tumor involvement. For example, enlarged nodes do not necessarily contain tumor, so biopsy is necessary before declaring the patient inoperable. As well, normal-sized nodes may contain tumor, and whether mediastinoscopy is required in such situations is controversial. Similarly, neither MRI nor CT is highly accurate in detecting mediastinal or chest-wall involvement, although certain specific features can occasionally be highly predictive of invasion.
Topics: Biopsy; Carcinoma, Bronchogenic; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Staging; Tomography, X-Ray Computed
PubMed: 8109104
DOI: 10.1007/BF01659077 -
Current Opinion in Pulmonary Medicine Jul 1995Progress in the treatment of bronchogenic carcinoma, the leading cause of cancer death in men and women in the United States, has been slow throughout the past few... (Review)
Review
Progress in the treatment of bronchogenic carcinoma, the leading cause of cancer death in men and women in the United States, has been slow throughout the past few years, and no major breakthroughs have occurred in the past 12 months. Significant developments in monoclonal antibody techniques and tissue cellular markers offer hope for improved diagnosis and are useful in staging and following disease response to treatment. Advances in patient selection and staging have been primarily responsible for improved surgical outcomes, but some new surgical alternatives like video-assisted thoracoscopy and other tissue-sparing procedures may offer reasonable outcomes with a lower morbidity. New drugs and new drug combinations are being evaluated with hematopoietic growth factors in the management of small cell lung cancer. Neoadjuvant chemotherapy and radiotherapy are finding a definite role in the management of non-small cell lung cancer. The optimal parameters for radiotherapy in the management of small cell lung cancer are being defined. The use of immunotoxins, adjuvant immunotherapy, and monoclonal antibodies offers major theoretical promise, but are as yet in the early stages of development. Ancillary techniques for palliation of local airway obstruction, including both laser and endobronchial stents, are proving beneficial in selected patients.
Topics: Carcinoma, Bronchogenic; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging
PubMed: 9363062
DOI: No ID Found -
Diseases of the Chest Feb 1968
Topics: Adult; Age Factors; Carcinoma, Bronchogenic; Cobalt Isotopes; Female; Humans; Male; Middle Aged; Radiography; Sex Factors
PubMed: 5635737
DOI: 10.1378/chest.53.2.183 -
Chest May 1989Minimal resection with curative intent for bronchogenic carcinoma was performed at our institutions in 15 patients from 1977 to 1987. All patients were stage I (T1N0 or... (Review)
Review
Minimal resection with curative intent for bronchogenic carcinoma was performed at our institutions in 15 patients from 1977 to 1987. All patients were stage I (T1N0 or T2N0). The five-year actuarial survival was 77 percent. The median length of follow-up for patients remaining alive was 41 months. There was a 6 percent (n = 1) local recurrence rate and a 27 percent (n = 3) distant recurrence rate. Both survival and recurrence rates are similar for minimal resection and for that being reported for lobectomy and pneumonectomy for stage I bronchogenic carcinoma. In our series, both median length of operating time and median length of postoperative hospital stay was less for those patients undergoing minimal resection for stage I bronchogenic carcinoma than for those undergoing lobectomy or pneumonectomy. Minimal resection can be considered as an acceptable treatment for bronchogenic carcinoma when technically possible in selected patients.
Topics: Aged; Carcinoma, Bronchogenic; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Prognosis
PubMed: 2651042
DOI: 10.1378/chest.95.5.968 -
Cancer Treatment Reviews Dec 1977
Review
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Drug Therapy, Combination; Humans; Immunotherapy; Neoplasm Staging; Time Factors
PubMed: 203396
DOI: 10.1016/s0305-7372(77)80001-7 -
Seminars in Oncology Sep 1974
Comparative Study Review
Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Communication; Humans; Lung Neoplasms; Lymphatic Metastasis; Palliative Care; Pneumonia; Radiotherapy; Radiotherapy Dosage
PubMed: 4143487
DOI: No ID Found -
Cancer Jan 1981Although blood spread of pulmonary malignancy presumably occurs through microembolization, frank embolization of tumor fragments is uncommon. The first reported case of... (Review)
Review
Although blood spread of pulmonary malignancy presumably occurs through microembolization, frank embolization of tumor fragments is uncommon. The first reported case of bronchogenic carcinoma appearing as a peripheral arterial embolus is described. The patient, a 64-year-old female, had acute ischemia of the left leg secondary to tumor embolism to the left profunda femoris and popliteal arteries. Shortly after embolectomy, she suffered atelectasis of the whole left lung from an epitheloid carcinoma in the left main bronchus. Twenty-eight cases of frank tumor embolism to the arterial tree occurring during the course of a noncardiac malignancy have been reported. None, however, occurred as an initial event. Pulmonary metastasis in patients with advanced malignancy was the source of the arterial emboli in 45% (13/29) of reported cases, but bronchogenic carcinoma was the original cell type in 38% (11/29) of cases. In general, arterial tumor embolism is a complication of advanced malignancy usually originating from one of multiple pulmonary metastases. This first case report of tumor embolism to a lower extremity occurring as the initial event in the clinical course of a bronchogenic carcinoma serves to emphasize the protein manifestations of malignant disease.
Topics: Angiography; Carcinoma, Bronchogenic; Embolism; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Popliteal Artery
PubMed: 7006796
DOI: 10.1002/1097-0142(19810115)47:2<398::aid-cncr2820470230>3.0.co;2-r